In India, the fidelity of electro convulsive therapy (ECT) devices is not regulated by any statutory body; as a result, it is conceivable that marketed devices may not meet the highest standards of quality. We therefore subjected 4 ECT devices, obtained from 4 different manufacturers, to quality testing in a biomedical engineering laboratory. The newest device was one month old, and the oldest device was 13 years old. Two devices were in regular use, and two were standby instruments, We found that not a single device was working in accordance with the manufacturer's specifications. One device was not working at all; one was delivering varying intensity, uninterrupted current rather than constant current brief pulses (whatever the settings applied); one was delivering blocks of pulses the description of which was enormously at variance with the instrument settings; and one device, the best of the four, was delivering brief-pulses with small errors in each setting that cumulated to an error of 49.3% at a common charge setting for clinical ECT. We conclude that clinicians must test the fidelity of their ECT devices at the time of purchase as well as at frequent intervals thereafter. Finally, the fidelity of ECT devices should be regulated by an appropriate statutory body in India
INTRODUCTION
Electroconvulsive therapy (ECT) is an important somatic treatment in psychiatry. ECT is delivered using a bioelectric device belonging to one of two broad categories: constant voltage, sinusoidal wave devices, or constant current, brief-pulse devices (Andrade, 1994) . Electrical aspects of ECT have assumed great importance during recent years because the extent to which the delivered stimulus exceeds the seizure threshold has been shown to direcdy relate to both benefits and adverse effects of the treatment (Sackeim et al, 1987a; 1993; . Electrical aspects of EXT have been well discussed elsewhere in mainstream psychiatric journals, emphasizing the need for clinicianf 1 ; in the field to familiarize themselves with the fundamentals of stimulus characteristics and dosing (Gordon, 1982; Railton et al, 1987; Gangadhar and Andrade, 1989 a and * b; Sackeim et al, 1994; Andrade, 1994 Andrade, & 2001 .
There are two reasons why clinicians should confirm that the ECT device delivers stimuli in accordance with the settings applied:
1. Settings that underestimate the electrical dose delivered expose the patient to an electrical charge that may be unnecessarily high. This may increase the cognitive adverse effects of ECT.
2. Settings that overestimate the electrical dose delivered expose the patient to a possibly inadequate electrical charge. This may compromise the therapeutic effects of the treatment. In India, the quality of many electrical devices is regulated by statutory bodies such as the Bureau of Indian Standards (BIS); regrettably, ECT devices are marketed with no formal quality control. Any person with any background can design, manufacture, and retail an ECT device.
K
It is therefore possible that some or many of the ECT devices supplied to ECT practitioners suffer from defects in quality We therefore tested a
We obtained four different ECT devices each supplied by a different Indian manufacturer. For reasons related to confidentiality, we are restrained from specifying either the manufacturer or the source of the device. The descriptions of the devices are as below :
1
Sinusoidal wave device. This device purported to deliver sinusoidal wave stimuli with voltage settings of 100-140 V in 10 V steps, and with stimulus duration settings of 0.3-0.7 s in 0.1 s steps. As far as could be ascertained, the device was approximately 13 years old.
2.
Trolley model brief pulse device. This device was designed to sit on a trolley, and purported to deliver unidirectional, constant current, brief-pulse stimuli. There were four levels of stimulus control. Pulse amplitude could be set at 500-800 mA in 100 mA steps; pulse width could be set at 1.0-2.2 ms in 0.2 ms steps; stimulus duration could be set at 1-4 s in 0.5 s steps; and, pulse frequency could be set at 60-120 Hz in 10 Hz steps. The device was approximately 6 years old.
3.
Briefcase model brief -pulse device. This device was the smallest into a briefcase, and purported to deliver constant current, brief-pulse stimuli. There were three levels of stimulus control. Pulse frequency could be set at 2-20 Hz in irregular, 2-4 Hz steps; stimulus duration could be set at 0.2-2.2 s in 0.2 steps (with a single jump from 1.4 to 1.8ins); and, energy delivered could be set at 20-40 Joules in 5 Joule steps. The device was approximately 7 years old.
4.
Compact model brief-pulse device. This device was the smallest and the most compact of the four. It purported to deliver bi-directional, constant current, brief pulse stimuli. There was only one level of control: stimulus duration could be set at 0.2 s, or at 0.4-3.6s in 0.4 s steps, in this device, pulse
amplitude was fixed at 800 mA, pulse width was fixed at 1.5 ms, and pulse frequency was fixed at 125 pulses per second (62.5 Hz). The device was approximately one month old. The sinusoidal wave device and the briefcase device were standby devices that were not in regular use. The trolley and compact devices were both in regular use at the locations from which they were sourced.
None of the devices had ever been opened, tested, serviced, or otherwise examined during their lifetime of use. None of the devices had ever been considered to have given any cause for concern at any time. All four devices were studied using the Digital Storagescope Oscilloscope (Iwatsu Electric Company, Japan) in the Biomedical Engineering Department of the National Institute of Mental Health and Neurosciences, Bangalore. Wherever relevant, the devices were tested against three resistances: 100 ohms, 140 ohms, and 220 ohms. These values were selected because patients commonly fall within this resistance range (Gordon, 1982) .
RESULTS
The Sinusoidal wave device was electrically inactive. The device was opened. Several malfunctioning components were identified. Further testing was deemed inadvisable as the defective components could occasion serious damage to the sensitive parts of the oscilloscope.The Trolley device was found to deliver stimuli that were entirely independent of the stimuli set; that is, none of the four stimulus control knobs were working at any of the instrument settings. Even more alarmingly, far from comprising briefpulses, the device output was found to comprise an uninterrupted flow of current which increased in amplitude with the passage of time during the delivery of the stimulus. Thus, the instrument was actually delivering substantially more electrical charge than it was supposed to deliver. Details of the output of the trolley device are presented in Table I . From the table, it is apparent that the stimulus amplitude increased progressively with increasing resistance and with increasing stimulus duration; formal inferential statistical analysis of these data was not possible because of the small number of individual data points (n = 4) for each cell, corresponding to the 4 possible current settings on the device. The data in Table 1 clearly indicate that the device was not delivering a constant current; variation in actual values, depending upon resistance and stimulus duration, ranged from a low All errors were positive in direction; that is, the actual value of stimulus duration was higher than the value set on the instrument. Continuous current; The direction of error was inconsistent; the actual value of frequency was higher than the value set at the lower end of the scale, and lower than the value set at the higher end of the scale. (not square) brief pulses. With different stimulus settings, there were 9-11 pulses per block, and the blocks were 96-106 ms in duration. Thus, each pulse was about 10 ms long. Stimulus durations showed a error of 10% to 130% in the direction of actual duration exceeding the set duration (Table  2 ). Pulse block frequency showed an error of 9.1% to 147.5%; the direction of error varied with the setting (Table 3) . It can be observed from Table 3 that, from pulse block frequency settings of 10 Hz onwards, current was flowing almost continuously. This is because each block of pulses was about 100 ms long; thus, with a frequency of 9 Hz upwards, the "current on" time per second extended for almost the whole second. With 100 ms duration blocks, the device frequency settings of 14 Hz upwards are logically impossible, which must have been why, at the setting of 20 Hz, the instrument was found to deliver continuous pulses. Variation in resistance was found to result in an exactly 100% variation in current amplitude; in contrast, the corresponding variation in voltage was just 10.4% (Table 4) . Thus, the briefcase model was a constant voltage, brief-pulse device: a biomedical anachronism. In view of the unusual voltage output of the device, the energy delivery Qoules) setting on the instrument could not be reliably tested. The compact device had three fixed settings: pulse width, pulse frequency, and pulse amplitude. The pulse width was fixed at 1.5 ms; this was found to be 1.6 ms on testing, a variation of 6.7%. The frequency of pulses was fixed at 62.5 Hz; the actual frequency was found to be 64.5 Hz, an error of 3.2%. The current amplitude was fixed at 800 mA; the actual current was 819 mA at 100 ohms resistance, 809 mA at 140 ohms, and 802 mA at 220 ohms, an error of 0.25% to 2.4%. The errors in stimulus duration were larger in range, and varied from 1.4% to 80%; there was a progressive decrease in the error percentage with increase in stimulus duration (Table 5) .With this device, every measured value for every variable was systematically in excess of the actual setting A quick calculation showed that at an instrument setting which was set to deliver a charge of 120 mC (80) mA x 1.5 ms 125 pulses per second x 0.8 s), the actual charge delivered was 179.2 mC; that is, a 49.3% excess in the delivery of charge.
DISCUSSION
Just as it is important to correcdy dose a drug during pharmacotherapy, so too is it necessary to correcdy dose an electrical stimulus during ECT (Sackeim et al 1987a (Sackeim et al & b, 1993 (Sackeim et al , 2000 . Therefore, just as the contents of a pill or capsule are required to meet the standards laid down by the Drug Controller of India, so too must the output of an ECT device meet the highest standards of fidelity.
Regrettably, no regulatory body specifies the range of permissible error in ECT devices, or monitors the fidelity of such devices at the time of marketing or later. We therefore conducted a study in order to determine whether devices in use are faithful to their output settings. The sinusoidal wave device was an instrument that was meant for use in case the device in regular use failed.
However, it was found to be out of order. 'Thus, its role as a standby device was defeated. Clearly, standby devices also require to be regularly checked. Jones (1974) reported the similar discovery of an electrically dead ECT device in active use in the UK. The trolley device was in regular use. Although it appeared to be working perfectly, none of the settings of pulse width, pulse amplitude, pulse frequency, and stimulus duration were actually working. Irrespective of the instrument settings applied, the instrument was found to be delivering a continuous current of amplitude that progressively increased with increase in (manually controlled) stimulus duration, rather than the brief pulses that it was supposed to deliver (Table 1) . Such a stimulus can do much harm to the patient because the large quantum of charge that is delivered to the brain can occasion serious cognitive deficits (Sackeim et al, 1991; Sackeim, 1992) Continuous local stimulation may also polarize tissues and cause skin burns at the site of electrode application (Andrade et al, 2001 ). This device was therefore a very unsafe one from more than one point of view Finally, with this device, the current amplitude varied by a factor of 167.5%; thus the device was neither constant current nor brief-pulse, as it was supposed to be. The briefcase device delivered blocks of pulses rather than individual pulses. These pulses were peaked, in contrast with the square waves that are the expected output of brief-pulse devices, 'the pulses were massed in blocks of approximately 10 per block, and each pulse was approximately 10 ms in width. These stimulus characteristics are wasteful in energy delivery because they stimulate the neurons during their refractory period; and, it is considered that large pulse widths, such as those exceeding 1 ms, may (241) be inefficient because the chronaxie of neurons in the mammalian nervous system is in the region of 0.1 -0.2 ms. (Sackeim, 1999; Andrade, 2001) . Thus, the stimulus waveform of this device was completely irrational the briefcase device, stimulus duration settings showed an error margin of up to 130% (Table 2) while stimulus frequency settings showed an error margin of up to 147.5% (Table 3) . Both these error values are unacceptably high. At the higher frequency settings on the device, the stimulus output comprised almost continuous waves of pulses; thus, the output of this device was potentially as dangerous as that of the trolley model (see discussion above). Finally, the device showed a wide variation (100%) in the current amplitude (Table 4) ; thus, this instrument, like the trolley device, was neither constant current nor brief pulse, as it purported to be. The compact device was the only instrument which delivered bidirectional brief pulses. An advantage of bidirectional stimulation is that it avoids the risk of polarization of tissue at the site of electrode application, and hence the risk of skin burns during ECT (Andrade et al, 2001 ). The brief pulses were square in shape, as claimed, and the error rate was a very modest 6.7% for pulse width, 3.2% for pulse frequency, and 2.4% (maximum) for current amplitude. These error values are generally considered acceptable within the limits of the mechanical components in electrical devices. Stimulus duration settings in the compact device, however, showed a wider margin of error; the error was as high as 80% at the lowest values of stimulus duration (Table 5) . At higher values of stimulus duration, however, the error fell to values of around 10% and less. This means that when administering supra threshold ECT, as is now deemed conventional the proportionate error in stimulus duration may not be large The compact device delivered stimuli with values that were all systematically greater than those set. Thus, the preceding discussion notwithstanding, patients receiving ECT with this model will be over stimulated, whatever the setting applied. The magnitude of overstimulation was calculated to be 49.3% at a stimulus setting that was supposed to be 120 mC, a common charge delivered during clinical ECT Thus, while this device was by far the best of the 4 tested, it still fell short of the ideal. A notable point is that the pulse characteristics of the compact device were within the conventionally acceptable range even if they exceeded the values set. This means that if this device is used to titrate the administered dose to the individual patient's seizure threshold, there is no risk of delivery of excess electrical charge; the error will remain in the documentation alone. Risk to the patient with this device exists only if charge is preset using a formula, as suggested by certain researchers (Petrides and Fink, 1996; Fink, 1997; Gangadhar et al, 1998; Girish et al 2000) ; in such an event, the device will deliver more than the actual charge set, leading to an increased risk of cognitive adverse effects. Our indictment of the ECT devices studied herein is subject to the following limitations: 1. We did not sample ECT devices from all ECT manufacturers in the country. Thus, it is conceivable that certain manufacturers retail high quality devices. However, this limitation does not detract from our finding that all four manufacturers whom we did address supplied instruments which, at the time of testing, were defective, or at least fell short of ideal srandards.2. We sampled only one device from each manufacturer. It is conceivable that other devices retailed by these manufacturers may have been better in quality. Unfortunately, it is logistically difficult if not impossible to obtain and test a large sample of devices from a single manufacturer. 3. The devices that we tested may have deteriorated with age. Thus, it is conceivable that new devices from these manufacturers may have been faithful to their settings. However, none of the devices had ever been considered to be defective, and one was practically off the shelf. Furthermore, many ECT devices in active use in ECT facilities in India are likely to be at least as old as certain of the devices we tested, if not older. Thus, our findings continue to be relevant to ECT practice in India.4. We tested only devices retailed by Indian manufacturers. Thus, it is conceivable that imported devices may be more accurate. However, it was the specific objective of our study to examine the fidelity of Indian devices because these are not regulated by statutory bodies. In conclusion. This study fidelity of 4 Indian ECT devices in the first study of its kind is India; in fact, to the best of our knowledge, the systematic testing of the fidelity of marketed ECT devices has never been reported anywhere else in the world. Although none of the devices tested had ever been considered to have given cause for concern, we found that one device was not working, one device was delivering continuous current rather than brief pulses, one was delivering stimuli that were far different from the actual settings, and one was delivering higher stimulus values than those set. The last mentioned device was the only truly constant current, brief-pulse device of the three that purported to belong to this class; nevertheless, the error margin in the last mentioned device was nearly 50% -at a charge of 120 mC, which is a common value in clinical ECT. It thus appears that, if our conclusions can be generalized to other ECT devices in the country, ECT as practiced in India may be, at best, substantially inaccurate from a dosimetric perspective and, at worst, shockingly unsafe. There is, therefore an urgent need for the statutory regulation of the fidelity of ECT devices in the country. In this context, the importance of a regulatory authority for ECT devices can be gauged from a recent editorial in the New England Journal of Medicine (Feigal et al, 2003) . In the USA, medical devices are categorized as high-, medium-, or low-risk. The manufacturers of high-risk devices, such as ECT instruments, require to furnish scientific clinical evidence to the Food and Drug Administration that the devices are safe and effective in order to receive marketing approval. Systems that monitor manufacturing quality, including plans for corrective and preventive actions, are also required. Finally: ECT practitioners should seek the assistance of a biomedical engineer to test the fidelity of their ECT devices at the time of purchase and periodically thereafter; a frequency of at least once yearly is recommended. In at least some centres in the USA, hospital regulations require devices used on patients to be tested for electrical safety every 6 months for some devices and annually for others (Max Fink, 2001; personal communication) . It is necessary for practice in India to meet these high but attainable standards of care.
